195 -5 (79) 2025 - Yusupov Sh.A., Kim O.V. - CHANGES IN BIOCHEMICAL PARAMETERS OF BONE METABOLISM IN ACUTE HEMATOGENOUS OSTEOMYELITIS IN CHILDREN

CHANGES IN BIOCHEMICAL PARAMETERS OF BONE METABOLISM IN ACUTE HEMATOGENOUS OSTEOMYELITIS IN CHILDREN

Yusupov Sh.A. - Samarkand State Medical University

Kim O.V. - Samarkand State Medical University

Atakulov J.O. - Samarkand State Medical University

Bayjigitov N.I. - Samarkand State Medical University

Rabbimova Z.Sh. - Samarkand State Medical University

Resume

Biochemical markers of bone collagen represent a new and promising tool in the diagnosis and monitoring of inflammatory bone diseases in children. The value of these markers lies in the fact that they allow earlier detection of pathological changes in bone tissue, determine the degree of bone damage, and can objectively assess the effectiveness of treatment and predict the outcome of the disease. The use of these biomarkers in clinical practice can improve not only the diagnosis of the disease, but also improve control over the effectiveness of treatment, as well as reduce the risk of complications.

Key words: Biomarkers of bone metabolism, collagen, PINP, β-CrossLaps, acute hematogenous osteomyelitis.

First page

958

Last page

961

For citation:Yusupov Sh.A., Kim O.V., Atakulov J.O., Bayjigitov N.I., Rabbimova Z.Sh. - CHANGES IN BIOCHEMICAL PARAMETERS OF BONE METABOLISM IN ACUTE HEMATOGENOUS OSTEOMYELITIS IN CHILDREN//New Day in Medicine 5(79)2025 958-961 https://newdayworldmedicine.com/en/new_day_medicine/5-79-2025

List of References

1. Баранов А.А., Степанов С.А. Остеомиелит у детей: современные подходы к диагностике и лечению // Педиатрия. 2020. – Т. 99, № 4. – С. 45–52.
2. Остроумова Т.М., Васильева А.В. Щелочная фосфатаза и β-crosslaps при остеомиелите у детей // Медицинская помощь. – 2021. – № 3. – С. 102–107.
3. Bianchi M.L. Biochemical markers in pediatric bone diseases. // Pediatr Nephrol. 2020;35(6):1019–1028.
4. Butolin E. G. Et al. Role of biomarkers of organic matrix of bone tissue in chronic hematogenous osteomyelitis in children // European journal of molecular medicine. – 2022. – Т. 2. – №. 5.
5. Carlsson A.C., et al. Longitudinal monitoring of β-crosslaps and PINP in children with bone infections. // Bone Joint Res. 2021;10(3):180–187.
6. Chanchlani R., et al. Clinical utility of serum calcium, phosphate and ALP in pediatric bone pathology. // J Bone Miner Metab. 2021;39(6):883–892.
7. Matsubara D, Tanaka H, et al. Clinical and laboratory characteristics of acute osteomyelitis in Japanese children. // J Infect Chemother. 2020;26(1):87–92.
8. Musayev S., Kim O. Significance of bone tissue organic matrix biomarkers in acute hematogenous osteomyelitis in children // Science and innovation. 2024;3(2):88-92.
9. Gkentzi D., et al. Biomarkers in children with acute osteomyelitis: diagnostic and prognostic value. // Eur J Pediatr. 2020;179(5):733–739.
10. Vladislavovna, K. O.и X. B. Fayzullayeva. «Possibilities of clinical application of organic bone matrix in chronic hematogenous osteomyelitis in children». SCHOLAR, т. 1, вып. 29, Zenodo, октябрь 2023 г., сс. 164–72, doi:10.5281/zenodo.10056481.
11. Ким О. В. Метаболизм коллагена // Zamonaviy ta'limda fan va innovatsion tadqiqotlar jurnali. – 2024;2(18):59-67.

    file

    download